Trial intelligence / Profile preview

Topical Insulin Dressing on Management of Diabetic Foot Ulcers

NCT07432581Completed

Sponsor
Cairo University
Start
Jan 2023
Primary completion
Jan 2024
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Trial of human insulin in diabetic foot ulcer (DFU) (2 arms), sponsored by Cairo University. Primary endpoint: Rate of diabetic foot ulcer healing at 12 weeks. Started Jan 2023; status: completed.

02

Drugs

human insulin
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT07432581.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07432581.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call